<p> Sanofi Pasteur acquired ShanH, which held majority stake in Shantha Biotechnics— a privately held maker of vaccines against Hepatitis B, Diphteria and Tetanus, among others. ShanH, the French subsidiary of Merieux Alliance, had bought stake in Shantha Biotechnics in November last year.<br /><br />Sanofi-aventis said in a statement that it has signed with Merieux Alliance a “strategic agreement for the acquisition by Sanofi Pasteur of Merieux Alliance’s French Subsidiary ShanH, which owns a majority stake in Vaccine company Shantha Biotechnics.”</p>
<p> Sanofi Pasteur acquired ShanH, which held majority stake in Shantha Biotechnics— a privately held maker of vaccines against Hepatitis B, Diphteria and Tetanus, among others. ShanH, the French subsidiary of Merieux Alliance, had bought stake in Shantha Biotechnics in November last year.<br /><br />Sanofi-aventis said in a statement that it has signed with Merieux Alliance a “strategic agreement for the acquisition by Sanofi Pasteur of Merieux Alliance’s French Subsidiary ShanH, which owns a majority stake in Vaccine company Shantha Biotechnics.”</p>